Tygacil Drug Use Investigation

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

116 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-04-15

Study Completion Date

2017-06-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Secondary Data Collection Study; safety and effectiveness of Tigecycline .under Japanese medical practice

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment

NCT01072539

Complicated Skin and Skin Structure Infections Complicated Intra-abdominal Infections Community-Acquired Bacterial Pneumonia

COMPLETED

Tigecycline for Treatment of Rapidly Growing Mycobacteria

NCT00600600

Mycobacterium Abscessus Lung Disease Rapidly Growing Mycobacterial Lung Disease

COMPLETED PHASE2

Clinical Effectiveness of a Once-daily Regimen of Tigecycline Compared to the Standard Regimen

NCT07258225

Multi Drug Resistant Infections

ACTIVE_NOT_RECRUITING PHASE4

Tigecycline In-Vitro Surveillance Study In Taiwan

NCT00488397

Community Acquired Infections

COMPLETED

Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.

NCT00205816

Bacterial Infections

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intra-Abdominal Infections Skin Disease, Infectious

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tigecycline (Tygacil)

Subjects who are treated with tigecycline

Tigecycline (Tygacil)

Intervention Type DRUG

Tigecycline 50 mg intravenously. Therapy conducted according to Japanese LPD of Tygacil. Tygacil will be dosed according to labeling. The administration and duration of the therapy will be determined by the treating physician to meet the patient individual needs for treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tigecycline (Tygacil)

Tigecycline 50 mg intravenously. Therapy conducted according to Japanese LPD of Tygacil. Tygacil will be dosed according to labeling. The administration and duration of the therapy will be determined by the treating physician to meet the patient individual needs for treatment.

Intervention Type DRUG